Yes, lupus can cause jaundice, though it’s not one of the more common symptoms. Jaundice, the yellowing of the skin and eyes from excess bilirubin in the blood, can develop in lupus patients through several different pathways: the disease attacking red blood cells, inflammation in the liver itself, or as a side effect of lupus medications. Understanding which mechanism is responsible matters because the treatments differ significantly.
How Lupus Leads to Jaundice
Lupus (systemic lupus erythematosus, or SLE) is an autoimmune disease, meaning the immune system mistakenly attacks the body’s own tissues. That attack can target almost any organ, and when it hits red blood cells or the liver, bilirubin levels rise. Bilirubin is a yellow pigment your body produces when it breaks down old red blood cells. Normally the liver processes bilirubin and clears it. If red blood cells are destroyed faster than usual, or if the liver can’t keep up with its processing job, bilirubin accumulates and your skin and eyes turn yellow.
There are three main routes this happens in lupus, and more than one can be active at the same time.
Autoimmune Hemolytic Anemia
The most well-known cause of jaundice in lupus is autoimmune hemolytic anemia (AIHA), a condition where the immune system produces antibodies that destroy red blood cells. When red blood cells break apart faster than the bone marrow can replace them, the excess bilirubin released into the bloodstream overwhelms the liver’s ability to clear it. The result is jaundice, often accompanied by fatigue, shortness of breath, a rapid heartbeat, and dark urine.
AIHA affects roughly 5 to 10% of people with lupus over the course of their disease. It can develop at any point, sometimes as one of the first signs of lupus and sometimes years after diagnosis. Blood tests typically reveal low red blood cell counts alongside elevated bilirubin and markers that confirm the cells are being destroyed rather than simply underproduced. Treatment usually involves immune-suppressing medications that stop the antibodies from attacking red blood cells, and most patients respond well.
Lupus Hepatitis and Liver Inflammation
Lupus can also directly inflame the liver, a condition called lupus hepatitis. Abnormal liver enzyme levels show up in an estimated 25 to 50% of SLE patients at some point, but clinically significant liver disease is much less common, occurring in fewer than 10% of cases. Lupus hepatitis specifically, where no other explanation for the liver inflammation can be found, is reported in roughly 3 to 23% of patients depending on the study.
Lupus hepatitis tends to produce mild to moderate elevations in liver enzymes rather than the dramatic spikes seen with drug-induced liver injury. In one prospective study, patients with lupus hepatitis had average enzyme levels about three to four times the upper limit of normal, while patients with drug-induced hepatitis had levels exceeding ten times normal. Jaundice from lupus hepatitis is possible but less common than from hemolytic anemia, and it typically signals more advanced liver inflammation.
One diagnostic challenge is distinguishing lupus hepatitis from autoimmune hepatitis, a separate liver disease that can overlap with lupus. The two conditions share many features, including similar antibody profiles and liver biopsy findings. When a patient meets the diagnostic criteria for both SLE and autoimmune hepatitis, they’re considered to have an overlap syndrome. The distinction matters because autoimmune hepatitis may require longer or different immunosuppressive therapy than lupus hepatitis alone.
Medication Side Effects
Some of the drugs used to treat lupus can themselves damage the liver and cause jaundice. Hydroxychloroquine, one of the most commonly prescribed lupus medications, is generally considered safe for the liver, but rare cases of serious liver toxicity have been documented. Patients in these reported cases typically developed fever, nausea, vomiting, abdominal pain, jaundice, and fatigue. Symptoms resolved after the medication was stopped.
NSAIDs (nonsteroidal anti-inflammatory drugs) like ibuprofen and indomethacin, which many lupus patients take for joint pain, have also been linked to liver injury in case reports. In several documented cases, patients taking these medications alongside hydroxychloroquine developed worsening jaundice, general malaise, and in severe instances, encephalopathy (confusion from the liver’s inability to clear toxins). Other lupus medications, including methotrexate and azathioprine, carry known risks of liver toxicity as well.
This is why lupus patients typically have their liver enzymes monitored through routine blood work. Catching a medication-related problem early, before jaundice develops, allows for a drug switch before serious damage occurs.
Rarer Causes Worth Knowing
Lupus can occasionally cause jaundice through less common mechanisms. Acute acalculous cholecystitis, inflammation of the gallbladder without gallstones, is an extremely rare manifestation of SLE with an incidence of less than 0.05% as an initial presentation. When it does occur, it can obstruct bile flow and lead to jaundice along with severe abdominal pain.
Pancreatitis, blood clots affecting the liver’s blood supply (particularly in patients with antiphospholipid syndrome, which often accompanies lupus), and protein deposits in the liver called amyloidosis are other uncommon but documented causes. These are rare enough that most lupus patients will never encounter them, but they illustrate why new jaundice in someone with lupus always warrants a thorough workup to identify the specific cause.
What Jaundice Looks Like in Practice
Jaundice usually starts subtly. The whites of the eyes yellow before the skin does, and in people with darker skin tones, the eyes and the inside of the mouth are the most reliable places to spot it. You might also notice dark tea-colored urine or pale, clay-colored stools, both signs that bilirubin isn’t being processed normally.
If you have lupus and notice yellowing, the diagnostic process typically involves blood tests to measure bilirubin levels, liver enzymes, and markers of red blood cell destruction. Your doctor will also review your current medications. Depending on the results, imaging of the liver and gallbladder or a liver biopsy may follow. The goal is to determine whether the jaundice stems from hemolysis, liver inflammation, a medication reaction, or a bile duct problem, since each requires a different approach.
The good news is that most causes of lupus-related jaundice respond to treatment. Hemolytic anemia typically improves with corticosteroids or other immunosuppressants. Lupus hepatitis often responds to the same immune-suppressing therapies used for other lupus flares. Drug-induced liver injury resolves once the offending medication is discontinued. The key is identifying the cause quickly, which is why new jaundice in a lupus patient is treated as something that needs prompt evaluation rather than a wait-and-see symptom.